Reunión Clínica Marzo 2022
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy Bartalena, L., Kahaly, G. J., Baldeschi, L., Dayan, C. M., Eckstein, A., Marcocci, C., Marinò, M., Vaidya, B., Wiersinga, W. M., & EUGOGO. (2021). European Journal of Endocrinology, 185(4), G43-G67. Retrieved Jan 13, 2022 DOI: https://eje.bioscientifica.com/view/journals/eje/185/4/EJE-21-0479.xml
Hypopituitarism and pregnancy: clinical characteristics, management and pregnancy outcome Aulinas, A., Stantonyonge, N., García-Patterson, A. et al. . Pituitary (2021).https://doi.org/10.1007/s11102-021-01196-7
Mechanisms of Weight Loss After Obesity SurgeryElina Akalestou, Alexander D Miras, Guy A Rutter, Carel W le RouxEndocrine Reviews, Volume 43, Issue 1, February 2022, Pages 19–34, DOI: https://doi.org/10.1210/endrev/bnab022
Hormone Therapy in Menopause: Concepts, Controversies, and Approach to TreatmentValerie A Flores, Lubna Pal, JoAnn E MansonEndocrine Reviews, Volume 42, Issue 6, December 2021, Pages 720–752, Published: 15 April 2021 Article history DOI: https://doi.org/10.1210/endrev/bnab011
Rare Causes of Hypercalcemia: 2021 UpdateYasaman Motlaghzadeh, John P Bilezikian, Deborah E SellmeyerThe Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 11, November 2021, Pages 3113–3128, Published: 08 July 2021 Article history DOI: https://doi.org/10.1210/clinem/dgab504
Procalcitonin as an Alternative Tumor Marker of Medullary Thyroid CarcinomaLuca Giovanella, Maria Luisa Garo, Luca Ceriani, Gaetano Paone, Alfredo Campenni’, Federica D’AurizioThe Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 12, December 2021, Pages 3634–3643, DOI: https://doi.org/10.1210/clinem/dgab564
Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes TechnologiesLin Y, Richardson C, Dobrin J, DeJonckheere M, Mizokami-Stout K, Fetters M et alDiabetes Care 2022;45(3):520–528https://doi.org/10.2337/dc21-1285
Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 DiabetesThe SURPASS-5 Randomized Clinical TrialDahl D, Onishi Y, Norwood P, Huh R, Bray R, Patel H et alJAMA. 2022;327(6):534-545.doi:10.1001/jama.2022.0078